Atherosclerosis

Nature

Volumn 407, Issue 6801, 2000, Pages 233-241

  Lusis, Aldons J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL METABOLISM; ENVIRONMENTAL FACTOR; GENETIC RISK; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CORONARY DISEASE; HUMANS; RISK ASSESSMENT;

EID: 0034648768     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35025203     Document Type: Review

References (72)

1. Tamminen, M., Mottino, G., Qiao, J. H., Breslow, J. L. & Frank, J. S. Ultrastructure of early lipid accumulation in apoE-deficient mice. Arterioscl. Thromb. Vasc. Biol. 19, 847-853 (1999).
2. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809 (1993).
3. Libby, P. Changing concepts of atherogenesis. J. Intern. Med. 247, 349-338 (1999).
4. Mehrabian, M., Wen, P.-Z., Fisler, J., Davis, R. C. & Lusis, A. J. Genetic locicontrolling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J. Clin. Invest. 101, 2485-2496 (1998).
5. Lusis, A. J., Weinreb, A. & Drake, T. A. in Textbook of Cardiovascular Medicine (ed. Topol, F., J.) 2389-2413 (Lippincott-Raven, Philadelphia, 1998).
6. Goldbourt, U. & Neufeld, H. N. Genetic aspects of arteriosclerosis. Arteriosclerosis 6, 357-377 (1988).
7. Smithies, O. & Maeda, N. Gene targeting approaches to complex diseases: atherosclerosis and essential hypertension. Proc. Natl Acad. Sci. USA 92, 5266-5272 (1995).
8. Gimbrone, M. A. Jr Vascular endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol. 155, 1-5 (1999).
9. Boren, J. et al. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J. Clin. Invest. 101, 2658-2664 (1998).
10. Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M. & Metcalfe, J. C. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 370, 460-162 (1994).
11. Goldstien, J. L., Ho, Y. K., Basu, S. K. & Brown, M. S. Binding sites on macrophages that mediate uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl Acad. Sci. USA 76, 333-337 (1979).
12. Cyrus, T. et al. Disruption of 12/i5-lipoxygenase diminishes atherosclerosis in apoE-deficient mice. J. Clin. J. Invest. 103, 1597-1604 (1999).
13. Hegele, R. A. Paraoxonase-genes and disease. Ann. Med. 31, 217-224 (1999).
14. Shih, D. M. et al. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem. 276, 17527-17535 (2000).
15. Watson, A. D. et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte-endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272, 13597-13607 (1997).
16. Knowles, J. W. et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-) apoE(-/-) mice are ameliorated by enalapril treatment. J. Clin. Invest. 105, 451-458 (2000).
17. Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (1999).
18. Dong, Z. M. et al. The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest. 102, 145-152 (1998).
19. Collins, R. G. et al. P-selectin or intercellular adhesion molecule (ICAM-1) deficiency substantially protects against atherosclerosis in apolipoprotein F-deficient mice. J. Exp. Med. 191, 189-194 (2000).
20. Shih, P. T. et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ. Res. 84, 345-351 (1998).
21. Gu, L. et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein-deficient mice. Mol. Cell 2, 275-281 (1998).
22. Boring, L., Gosling, J., Cleary, M. & Charo, I. F. Decreased lesion formation in CCR2-/-mice reveals a role far chemokines in the initiation of atherosclerosis. Nature 394, 894-897 (1998).
23. Smith, J. D. et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl Acad. Sci. USA 92, 8264-8268 (1995).
24. Podrez, F. A. et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105, 1095-1108 (2000).
25. Marathe, S., Kuriakose, G., Williams, K. J. & Tabas, I. Sphingomyclinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscl. Thromb. Vasc. Biol. 19, 2648-2658 (1999).
26. 2, Arterioscl. Thromb. Vasc. Biol. 19, 1284-1290 (1994).
27. Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-296, (1997).
28. Febbraio, M. et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerosis lesion development in mice. J. Clin. Invest. 105, 1049-1056 (2000).
29. Tontonoz, P., Nagy, L., Alvarez, J. L., Thomazy, V. A. & Evans, R. M. PPAR gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252 (1998).
30. Fazio, S. et al. Increased atherogenesis in mice reconstituted with apolipoprotein E null macrophages. Proc. Natl Acad. Sci. USA 94, 4647-4652 (1997).
31. Accad, M. et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase I. J. Clin. Invest. 105, 711-719 (2000).
32. Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F. & Libhy, P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc. Natl Acad. Sci. USA 97, 7458-7463 (2000).
33. Fyfe, A. J., Qiao, J. H. & Lusis, A. J. Immune deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J. Clin. Invest. 94, 2516-2520 (1994).
34. Shaw, P. X. et al. Natural antibodies with T15 idiotype may act in aihemsclerosis apoptotic clearance and protective immunity. J. Clin. Invest. 105, 1731-1740 (2000).
35. Gupta, S. et al. IFN-γ potentiates atherosclerosis in apoE knock-out mice. J. Clin. Invest. 99, 2752-2761 (1997).
36. Gerhard, G. T. & Duell, P. B. Homocysteine and atherosclerosis. Curr. Opin. Lipidol. 10, 417-429 (1999).
37. Negoro, N. et al. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy. J. Clin. Invest. 95, 1140-1150 (1995).
38. Nathan, L. & Chaudhuri, G. Estrogens and atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 37, 477-515 (1997).
39. Streblow, D. N. et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99, 511-520 (1999).
40. Guevara, N. V., Kim, H.-S., Antonova, E. L. & Chan, L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nature Med. 5, 335-339 (1999).
41. Schwartz, S. M. & Murray, C. E. Proliferation and the monoclonal origin of atherosclerotic lesions. Annu. Rev. Med. 49, 437-460 (1998).
42. Watson, K. E. et al. TGF-β1 and 25-hydroxycholesterol stimulate steoblasl-like vascular cells to calcify. J. Clin. Invest. 93, 2106-2113 (1994).
43. Moultan, K. S. & Folkman, J. in Molecular Rasis of Cardiovascular Diseases (ed. Chien, K. R.) 393-410 (Saunders, Philadelphia, 1999).
44. Schonheck, U. et al. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am. J. Pathol. 156, 7-14 (2000).
45. Young, S. G. & Fielding, C. J. The ABCs of cholesterol efflux. Nature Genet. 22, 316-318 (1999).
46. Orsó, E. et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and ABC1-deficient mice. Nature Genet. 24, 192-196 (2000).
47. Geller, D. S. et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289, 119-123 (2000).
48. Cargill, M. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22, 231-238 (1999).
49. Krushkal, I. et al. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99, 1407-1410 (1999).
50. Stoll, M. et al. New target regions for human hypertension via comparative genomics. Genome Res. 10, 473-482 (2000).
51. Aitman, T. J. et al. Identification of CD36(Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genet. 21, 76-83 (1999).
52. Shi, W., Haberland, M. E., Jien, M. L., Shih, D. M. & Lusis, A. J. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102, 75-81 (2000).
53. Kisch, N. J. Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
54. Assmann, G., Cullen, P., Jossa, F., Lewis, B. & Mancini, M. Coronary heart disease: reducing the risk. Arterioscl. Thromb. Vasc. Biol. 19, 1819-1824 (1999).
55. Navab, M. et al. The yin and the yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscl Thromb. Vasc. Biol. 16, 831-842 (1996).
56. Desumont, C. et al. Complete atheroscletosis regression after human apoE gene transfer in apoE deficient/nude mice. Arterioscl. Thromb. Vasc. Biol. 20, 435-142 (2000).
57. Herrera, V. L. et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nature Med. 5, 1383-1389 (1999).
58. Gordon, D. J. & Rifkind, B. M. High-density liproprotein - the clinical implications of recent studies. N. Engl. J. Med. 321, 1311-1316 (1989).
59. Kronenberg, F. et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis, Circulation 100, 1154-1160 (1999).
60. Luft, F. C. Molecular genetics of human hypertension. J. Hypertens. 16, 1871-1878 (1998).
61. Glassman, A. H. & Shapito, P. A. Depression and the course of coronary artery disease. Am. J. Psychiatry 155, 4-11 (1998).
62. 2 predict coronary events in patients with coronary artery disease. Circulation 100, 1280-1284 (1999).
63. Steinberg, D. & Witztum, J. L. in Molecular Basis of Cardiovascular Disease (ed. Chien, K. R.) 458-475 (Saunders, Philadelphia, 1999).
64. Hu, H., Pierce, G. N. & Zhong, G. The atherogenic effects of chlamydia are dependent on scrum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103, 747-753 (1999).
65. Cohen, J. C., Wang, Z., Grundy, S. M., Stoesz, M. R. & Guerra, R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94, 2377-2384 (1994).
66. Wittrup, H. H., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart diseases: a meta-analysis. Circulation 99, 2901-2907 (1999).
67. Samani, N. J., Thompson, J. R., O'Toole, L., Channer, K. & Woods, K. L. A meta-analysis of the association of the deletion allele of the antiogensin-converting enzyme gene with myocardial infarction. Circulation 94, 708-712 (1996).
68. Tuomainen, T.-P. et al. Increased risk of acute myocardial infarction in carriers of the hemachromatosis gene Cys282 Tyr mutation. Circulation 100, 1274-1279 (1999).
69. Hingorani, A. D. et al. A common variant of the endothelial nitric oxide synthase (Glu298 → Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100, 1515-1520 (1999).
70. Franco, R. F. et al. Factor XIII and the risk of myocardial infarction. Haematologica 85, 67-71 (2000).
71. Nievelstein-Post, P., Mottino, G., Fogelman, A. & Frank, J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscl. Thromb. Vasc. Biol. 14, 1151-1161 (1994).
72. Nievelstein, P. F., Fogelman, A. M., Mottino, G. & Frank, J. S. Lipid accumulation in rabbit aorta intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscl. Thromb. Vasc. Biol. 11, 1795-1805 (1991).